SANDLER ALAN B. (Chief Development Officer) sold 0.6% of their position (341.00 shares) of REVOLUTION MEDICINES, INC. on the open market
Open‑market sale worth $67.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/18/2026ACC: 0001835966-26-000006
Officer· Chief Development Officer
Since Mar 2026
-341.00
Net shares
Net seller
$67.9K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
341.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.00
Price / share
$194.96
Trade value
$974.79
% of position
0.0%
9/16/2026
53.21K→53.20K
Common Stock
Direct
Shares
−336.00
Price / share
$199.30
Trade value
$66.97K
% of position
0.6%
9/16/2026
53.20K→52.87K
Total
Net shares
−341.00
Net value
-$67.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/16/2026 | S · Sale | −5.00 | $194.96 | $974.79 | 0.0% | 53.21K | 53.20K |
| Common Stock Direct | 9/16/2026 | S · Sale | −336.00 | $199.30 | $66.97K | 0.6% | 53.20K | 52.87K |
| Total | −341.00 | -$67.94K | ||||||
Derivative Transactions0
No derivative transactions reported